Melanoma cells were shown to be composed of heterogeneous cancer cells that, when expressing high levels of KDM5B, are resistant to therapy such as MAPK inhibition, giving rise to tumor repopulation after initial therapy (Roesch et al., 2010). This evidence concerns the gene KDM5B and cancer.